Ceapro Inc. 7824 – 51 Avenue Edmonton, AB T6E 6W2 Canada 780-421-4555 http://www.ceapro.com Ceapro Inc., a biotechnology company, develops, commercializes, and markets health and wellness products, and technology relating to plant extracts in Canada, the United States, Germany, and other countries. Its products comprise natural active ingredients, including beta glucan, avenanthramides, oat powder, oat oil, oat peptides, and lupin peptides that are marketed to personal care, cosmetic, medical, and animal health industries through its distribution partners and direct sales; and veterinary therapeutic products, such as an oat shampoo, an ear cleanser, and a dermal complex/conditioner for veterinarians in Japan and Asia. The company’s products and technologies under research and development, or pre-commercial stage include a platform using its beta glucan formulations to deliver compounds for treatments in the personal and healthcare sectors; an extension to the active ingredients product range; various novel enabling technologies, including Pressurized Gas Expansion drying technology; new oat variety and technologies to enhance the content of avenanthramides; and CeaProve, a diabetes test meal to screen pre-diabetes and to confirm diabetes diagnosis. Ceapro Inc. was incorporated in 1997 and is headquartered in Edmonton, Canada.